BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 35413227)

  • 1. Blockade of chloride channel-3 enhances cisplatin sensitivity of cholangiocarcinoma cells though inhibiting autophagy.
    Han Y; Zhou Y; Zhou L; Jia X; Yu X; An X; Shi Z
    Can J Physiol Pharmacol; 2022 Jul; 100(7):584-593. PubMed ID: 35413227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autophagy inhibitor chloroquine increases sensitivity to cisplatin in QBC939 cholangiocarcinoma cells by mitochondrial ROS.
    Qu X; Sheng J; Shen L; Su J; Xu Y; Xie Q; Wu Y; Zhang X; Sun L
    PLoS One; 2017; 12(3):e0173712. PubMed ID: 28301876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of ClC-5 suppresses proliferation and induces apoptosis in cholangiocarcinoma cells through the Wnt/β-catenin signaling pathway.
    Shi Z; Zhou L; Zhou Y; Jia X; Yu X; An X; Han Y
    BMB Rep; 2022 Jun; 55(6):299-304. PubMed ID: 35651328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of Wnt/β-catenin signaling downregulates P-glycoprotein and reverses multi-drug resistance of cholangiocarcinoma.
    Shen DY; Zhang W; Zeng X; Liu CQ
    Cancer Sci; 2013 Oct; 104(10):1303-8. PubMed ID: 23822562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of NF-κB Activity Enhances Sensitivity to Anticancer Drugs in Cholangiocarcinoma Cells.
    Seubwai W; Vaeteewoottacharn K; Kraiklang R; Umezawa K; Okada S; Wongkham S
    Oncol Res; 2016 Jan; 23(1-2):21-8. PubMed ID: 26802647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of active autophagy induces apoptosis and increases chemosensitivity in cholangiocarcinoma.
    Hou YJ; Dong LW; Tan YX; Yang GZ; Pan YF; Li Z; Tang L; Wang M; Wang Q; Wang HY
    Lab Invest; 2011 Aug; 91(8):1146-57. PubMed ID: 21647092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Albendazole-induced autophagy blockade contributes to elevated apoptosis in cholangiocarcinoma cells through AMPK/mTOR activation.
    He Q; Yin Y; Pan X; Wu Y; Li X
    Toxicol Appl Pharmacol; 2022 Nov; 454():116214. PubMed ID: 36055539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nrf2 inhibition sensitizes cholangiocarcinoma cells to cytotoxic and antiproliferative activities of chemotherapeutic agents.
    Samatiwat P; Prawan A; Senggunprai L; Kukongviriyapan U; Kukongviriyapan V
    Tumour Biol; 2016 Aug; 37(8):11495-507. PubMed ID: 27015836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural compound oblongifolin C inhibits autophagic flux, and induces apoptosis and mitochondrial dysfunction in human cholangiocarcinoma QBC939 cells.
    Zhang A; He W; Shi H; Huang X; Ji G
    Mol Med Rep; 2016 Oct; 14(4):3179-83. PubMed ID: 27499017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Capsaicin Enhances the Drug Sensitivity of Cholangiocarcinoma through the Inhibition of Chemotherapeutic-Induced Autophagy.
    Hong ZF; Zhao WX; Yin ZY; Xie CR; Xu YP; Chi XQ; Zhang S; Wang XM
    PLoS One; 2015; 10(5):e0121538. PubMed ID: 25933112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. YTHDF2 promotes intrahepatic cholangiocarcinoma progression and desensitises cisplatin treatment by increasing CDKN1B mRNA degradation.
    Huang CS; Zhu YQ; Xu QC; Chen S; Huang Y; Zhao G; Ni X; Liu B; Zhao W; Yin XY
    Clin Transl Med; 2022 Jun; 12(6):e848. PubMed ID: 35696608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic Phenotyping Predicts Gemcitabine and Cisplatin Chemosensitivity in Patients With Cholangiocarcinoma.
    Suksawat M; Phetcharaburanin J; Klanrit P; Namwat N; Khuntikeo N; Titapun A; Jarearnrat A; Vilayhong V; Sa-Ngiamwibool P; Techasen A; Wangwiwatsin A; Mahalapbutr P; Li JV; Loilome W
    Front Public Health; 2022; 10():766023. PubMed ID: 35223723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of chloride channel 3 expression facilitates sensitivity of human glioma U251 cells to cisplatin through concomitant inhibition of Akt and autophagy.
    Su J; Xu Y; Zhou L; Yu HM; Kang JS; Liu N; Quan CS; Sun LK
    Anat Rec (Hoboken); 2013 Apr; 296(4):595-603. PubMed ID: 23408563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salubrinal Enhances Doxorubicin Sensitivity in Human Cholangiocarcinoma Cells Through Promoting DNA Damage.
    Yu W; Xiang Y; Luo G; Zhao X; Xiao B; Cheng Y; Feng C; Duan C; Xia X; Wong VKW; Dai R
    Cancer Biother Radiopharm; 2018 Aug; 33(6):258-265. PubMed ID: 29957018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Babaodan overcomes cisplatin resistance in cholangiocarcinoma via inhibiting YAP1.
    Li J; Ma X; Xu F; Yan Y; Chen W
    Pharm Biol; 2024 Dec; 62(1):314-325. PubMed ID: 38571483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulation of retinoic acid receptor-β reverses drug resistance in cholangiocarcinoma cells by enhancing susceptibility to apoptosis.
    Ren HY; Chen B; Huang GL; Liu Y; Shen DY
    Mol Med Rep; 2016 Oct; 14(4):3602-8. PubMed ID: 27599527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of autophagy improves resistance and enhances sensitivity of gastric cancer cells to cisplatin.
    Hou G; Bai Y; Jia A; Ren Y; Wang Y; Lu J; Wang P; Zhang J; Lu Z
    Can J Physiol Pharmacol; 2020 Jul; 98(7):449-458. PubMed ID: 32058824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MRP3-Mediated Chemoresistance in Cholangiocarcinoma: Target for Chemosensitization Through Restoring SOX17 Expression.
    Lozano E; Asensio M; Perez-Silva L; Banales JM; Briz O; Marin JJG
    Hepatology; 2020 Sep; 72(3):949-964. PubMed ID: 31863486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. mir-637 inhibits the proliferation of cholangiocarcinoma cell QBC939 through interfering CTSB expression.
    Li JX; Ding XM; Han S; Wang K; Jiao CY; Li XC
    Eur Rev Med Pharmacol Sci; 2018 Mar; 22(5):1265-1276. PubMed ID: 29565483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upregulation of TTYH3 promotes epithelial-to-mesenchymal transition through Wnt/β-catenin signaling and inhibits apoptosis in cholangiocarcinoma.
    Xue W; Dong B; Zhao Y; Wang Y; Yang C; Xie Y; Niu Z; Zhu C
    Cell Oncol (Dordr); 2021 Dec; 44(6):1351-1361. PubMed ID: 34796468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.